165 related articles for article (PubMed ID: 35026405)
1. Evaluation of the analgesic effect of ɑ-lipoic acid in treating pain disorders: A systematic review and meta-analysis of randomized controlled trials.
Cassanego G; Rodrigues P; De Freitas Bauermann L; Trevisan G
Pharmacol Res; 2022 Mar; 177():106075. PubMed ID: 35026405
[TBL] [Abstract][Full Text] [Related]
2. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.
Ziegler D; Nowak H; Kempler P; Vargha P; Low PA
Diabet Med; 2004 Feb; 21(2):114-21. PubMed ID: 14984445
[TBL] [Abstract][Full Text] [Related]
3. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
[TBL] [Abstract][Full Text] [Related]
4. Effects of Oral Alpha-Lipoic Acid Treatment on Diabetic Polyneuropathy: A Meta-Analysis and Systematic Review.
Hsieh RY; Huang IC; Chen C; Sung JY
Nutrients; 2023 Aug; 15(16):. PubMed ID: 37630823
[TBL] [Abstract][Full Text] [Related]
5. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.
Ziegler D; Ametov A; Barinov A; Dyck PJ; Gurieva I; Low PA; Munzel U; Yakhno N; Raz I; Novosadova M; Maus J; Samigullin R
Diabetes Care; 2006 Nov; 29(11):2365-70. PubMed ID: 17065669
[TBL] [Abstract][Full Text] [Related]
6. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).
Ziegler D; Hanefeld M; Ruhnau KJ; Meissner HP; Lobisch M; Schütte K; Gries FA
Diabetologia; 1995 Dec; 38(12):1425-33. PubMed ID: 8786016
[TBL] [Abstract][Full Text] [Related]
7. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy.
Ziegler D; Gries FA
Diabetes; 1997 Sep; 46 Suppl 2():S62-6. PubMed ID: 9285502
[TBL] [Abstract][Full Text] [Related]
8. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
Ziegler D
Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113
[TBL] [Abstract][Full Text] [Related]
9. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
Ametov AS; Barinov A; Dyck PJ; Hermann R; Kozlova N; Litchy WJ; Low PA; Nehrdich D; Novosadova M; O'Brien PC; Reljanovic M; Samigullin R; Schuette K; Strokov I; Tritschler HJ; Wessel K; Yakhno N; Ziegler D;
Diabetes Care; 2003 Mar; 26(3):770-6. PubMed ID: 12610036
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.
Hahm JR; Kim BJ; Kim KW
J Diabetes Complications; 2004; 18(2):79-85. PubMed ID: 15120701
[TBL] [Abstract][Full Text] [Related]
11. Oxycodone for neuropathic pain and fibromyalgia in adults.
Gaskell H; Moore RA; Derry S; Stannard C
Cochrane Database Syst Rev; 2014 Jun; (6):CD010692. PubMed ID: 24956205
[TBL] [Abstract][Full Text] [Related]
12. [α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy].
Strokov IA; Phokina AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3):50-55. PubMed ID: 28399096
[TBL] [Abstract][Full Text] [Related]
13. Oxcarbazepine for neuropathic pain.
Zhou M; Chen N; He L; Yang M; Zhu C; Wu F
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD007963. PubMed ID: 29199767
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of α-lipoic acid in diabetic neuropathy.
Papanas N; Ziegler D
Expert Opin Pharmacother; 2014 Dec; 15(18):2721-31. PubMed ID: 25381809
[TBL] [Abstract][Full Text] [Related]
15. Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis.
Prado MB; Adiao KJB
Can J Diabetes; 2024 Jun; 48(4):233-243.e10. PubMed ID: 38295879
[TBL] [Abstract][Full Text] [Related]
16. A Case for Alpha-Lipoic Acid as an Alternative Treatment for Diabetic Polyneuropathy.
Nguyen N; Takemoto JK
J Pharm Pharm Sci; 2018; 21(1s):177s-191s. PubMed ID: 30139425
[TBL] [Abstract][Full Text] [Related]
17. Gabapentin for chronic neuropathic pain in adults.
Wiffen PJ; Derry S; Bell RF; Rice AS; Tölle TR; Phillips T; Moore RA
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007938. PubMed ID: 28597471
[TBL] [Abstract][Full Text] [Related]
18. Treatment with α-Lipoic Acid over 16 Weeks in Type 2 Diabetic Patients with Symptomatic Polyneuropathy Who Responded to Initial 4-Week High-Dose Loading.
Garcia-Alcala H; Santos Vichido CI; Islas Macedo S; Genestier-Tamborero CN; Minutti-Palacios M; Hirales Tamez O; García C; Ziegler D
J Diabetes Res; 2015; 2015():189857. PubMed ID: 26345602
[TBL] [Abstract][Full Text] [Related]
19. Gabapentin for chronic neuropathic pain and fibromyalgia in adults.
Moore RA; Wiffen PJ; Derry S; Toelle T; Rice AS
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD007938. PubMed ID: 24771480
[TBL] [Abstract][Full Text] [Related]
20. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
Ziegler D; Reljanovic M; Mehnert H; Gries FA
Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]